One important metric to look for in a stock is an 80 or higher Relative Strength Rating. Natera now clears that threshold, with a jump from 78 to 81 Friday.
Hone Your Stock-Picking Skills By Focusing On These Factors
IBD's proprietary RS Rating tracks technical performance by using a 1 (worst) to 99 (best) score that shows how a stock's price action over the last 52 weeks matches up against other publicly traded companies.
Decades of market research reveals that the stocks that go on to make the biggest gains often have an RS Rating of over 80 in the early stages of their moves.
Natera is working on a consolidation with a 183.00 entry. See if the stock can break out in heavy volume. It's a later-stage pattern, and investors should be aware that those are less likely to work.
The company posted 0% earnings growth in its most recent report. Sales increased 36%.
The company holds the No. 13 rank among its peers in the Medical-Services industry group. Hims & Hers Health, Option Care Health and iRhythm Technologies are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Rising Relative Strength?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
